OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EGFR inhibitors and apoptotic inducers: Design, synthesis, anticancer activity and docking studies of novel xanthine derivatives carrying chalcone moiety as hybrid molecules
Hesham A. Abou‐Zied, Bahaa G. M. Youssif, Mamdouh F. A. Mohamed, et al.
Bioorganic Chemistry (2019) Vol. 89, pp. 102997-102997
Closed Access | Times Cited: 116

Showing 26-50 of 116 citing articles:

Design and synthesis of new 1,6-dihydropyrimidin-2-thio derivatives targeting VEGFR-2: Molecular docking and antiproliferative evaluation
Adel A. Marzouk, Salah A. Abdel‐Aziz, Kamal Abdelrahman, et al.
Bioorganic Chemistry (2020) Vol. 102, pp. 104090-104090
Closed Access | Times Cited: 45

Design, Synthesis, and Antibacterial Screening of Some Novel Heteroaryl-Based Ciprofloxacin Derivatives as DNA Gyrase and Topoisomerase IV Inhibitors
Lamya H. Al-Wahaibi, Amer A. Amer, Adel A. Marzouk, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 5, pp. 399-399
Open Access | Times Cited: 38

Design, synthesis, biological assessment, and in-Silico studies of 1,2,4-triazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors
Heba S. Mohamed, Noha H. Amin, Mohammed T. El‐Saadi, et al.
Bioorganic Chemistry (2022) Vol. 121, pp. 105687-105687
Closed Access | Times Cited: 25

Synthesis and Biological Evaluation of Indole-2-Carboxamides with Potent Apoptotic Antiproliferative Activity as EGFR/CDK2 Dual Inhibitors
Lamya H. Al-Wahaibi, Yaser A. Mostafa, Mostafa Abdelrahman, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 1006-1006
Open Access | Times Cited: 22

Design, Synthesis, and Antiproliferative Activity of New 5-Chloro-indole-2-carboxylate and Pyrrolo[3,4-b]indol-3-one Derivatives as Potent Inhibitors of EGFRT790M/BRAFV600E Pathways
Lamya H. Al-Wahaibi, Anber F. Mohammed, Mostafa Abdelrahman, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1269-1269
Open Access | Times Cited: 14

Marine-derived EGFR inhibitors: novel compounds targeting breast cancer growth and drug resistance
Qi Li, Bo Li, Qian Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4

Biological Role of Chalcones in Medicinal Chemistry
Sunil U. Tekale, Samson S. Mashele, Ofentse Jacob Pooe, et al.
IntechOpen eBooks (2020)
Open Access | Times Cited: 34

Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study
Tarek S. Ibrahim, Ahmad J. Almalki, Amr H. Moustafa, et al.
Bioorganic Chemistry (2021) Vol. 111, pp. 104885-104885
Closed Access | Times Cited: 31

Design, synthesis and chemoinformatic studies of new thiazolopyrimidine derivatives as potent anticancer agents via phosphodiesterase-5 inhibition and apoptotic inducing activity
Mohamed T. M. Nemr, Mohamed A. Mohamed Teleb, Asmaa M. AboulMagd, et al.
Journal of Molecular Structure (2022) Vol. 1272, pp. 134216-134216
Closed Access | Times Cited: 20

Design, synthesis, apoptotic, and antiproliferative effects of 5-chloro-3- (2-methoxyvinyl)-indole-2-carboxamides and pyrido[3,4-b]indol-1-ones as potent EGFR WT/ EGFR T790M inhibitors
Lamya H. Al-Wahaibi, Anber F. Mohammed, Fatema El-Zahraa S. Abdel Rahman, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 11

Recent Progresses in Chalcone Derivatives as Potential Anticancer Agents
Jiahui Yang, Jianmei Lv, Shuxian Cheng, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 11, pp. 1265-1283
Closed Access | Times Cited: 10

Design, Synthesis, and Anti-Proliferative Action of Purine/Pteridine-Based Derivatives as Dual Inhibitors of EGFR and BRAFV600E
Samar El‐Kalyoubi, Hesham A. M. Gomaa, Elshimaa M. N. Abdelhafez, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 716-716
Open Access | Times Cited: 10

Design and synthesis of some new imidazole-morpholine-1,2,4-oxadiazole hybrids as EGFR targeting in vitro anti-breast cancer agents
Praveen kumar Kannekanti, Satheesh Kumar Nukala, Srinivas Bandari, et al.
Journal of Molecular Structure (2024) Vol. 1310, pp. 138209-138209
Closed Access | Times Cited: 3

Synthesis of novel benzimidazole–oxadiazole derivatives as potent anticancer activity
Ulviye Acar Çevik, Derya Osmani̇ye, Betül Kaya Çavuşoğlu, et al.
Medicinal Chemistry Research (2019) Vol. 28, Iss. 12, pp. 2252-2261
Closed Access | Times Cited: 31

Design, synthesis and anticancer activity of novel valproic acid conjugates with improved histone deacetylase (HDAC) inhibitory activity
Tarek S. Ibrahim, Taghreed A. Sheha, Nader E. Abo‐Dya, et al.
Bioorganic Chemistry (2020) Vol. 99, pp. 103797-103797
Closed Access | Times Cited: 31

Synthesis, EGFR-TK inhibition and anticancer activity of new quinoxaline derivatives
Eman A. Ahmed, Mamdouh F. A. Mohamed, Ahmed Omran, et al.
Synthetic Communications (2020) Vol. 50, Iss. 19, pp. 2924-2940
Closed Access | Times Cited: 28

Novel chalcone/aryl carboximidamide hybrids as potent anti-inflammatory via inhibition of prostaglandin E2 and inducible NO synthase activities: design, synthesis, molecular docking studies and ADMET prediction
Tarek S. Ibrahim, Amr H. Moustafa, Ahmad J. Almalki, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1067-1078
Open Access | Times Cited: 24

One-Pot Synthesis of 1-Thia-4-azaspiro[4.4/5]alkan-3-ones via Schiff Base: Design, Synthesis, and Apoptotic Antiproliferative Properties of Dual EGFR/BRAFV600E Inhibitors
Lamya H. Al-Wahaibi, Essmat M. El‐Sheref, Mohamed M. Hammouda, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 467-467
Open Access | Times Cited: 9

Novel urea linked ciprofloxacin-chalcone hybrids having antiproliferative topoisomerases I/II inhibitory activities and caspases-mediated apoptosis
Hamada H. H. Mohammed, Samar H. Abbas, Alaa M. Hayallah, et al.
Bioorganic Chemistry (2020) Vol. 106, pp. 104422-104422
Closed Access | Times Cited: 26

Isolation and characterization of novel acetylcholinesterase inhibitors from Ficus benghalensis L. leaves
Heba Ali Hassan, Ahmed E. Allam, Dalia H. Abu‐Baih, et al.
RSC Advances (2020) Vol. 10, Iss. 60, pp. 36920-36929
Open Access | Times Cited: 23

Design and synthesis of new pyranoquinolinone heteroannulated to triazolopyrimidine of potential apoptotic antiproliferative activity
Mohamed Ramadan, Mohamed Abd Elaziz, Yaseen A. M. M. Elshaier, et al.
Bioorganic Chemistry (2020) Vol. 105, pp. 104392-104392
Open Access | Times Cited: 23

Novel 1,2,4-oxadiazole/pyrrolidine hybrids as DNA gyrase and topoisomerase IV inhibitors with potential antibacterial activity
Firas Obaid Arhema Frejat, Yaquan Cao, Hongjin Zhai, et al.
Arabian Journal of Chemistry (2021) Vol. 15, Iss. 1, pp. 103538-103538
Open Access | Times Cited: 21

Synthesis and molecular docking of new N4-piperazinyl ciprofloxacin hybrids as antimicrobial DNA gyrase inhibitors
Hamada H. H. Mohammed, Doaa Mohamed Elroby Ali, Mohamed Badr, et al.
Molecular Diversity (2022) Vol. 27, Iss. 4, pp. 1751-1765
Open Access | Times Cited: 15

Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAFV600E with promising antiproliferative properties
Hesham A. Abou‐Zied, Eman A. M. Beshr, Hesham A. M. Gomaa, et al.
Archiv der Pharmazie (2022) Vol. 356, Iss. 4
Closed Access | Times Cited: 15

Scroll to top